Ads
related to: ankylosing spondylitis prevalence chart cdc adults- $0 Co-Pay Offer
See If You're Eligible For A $0
Co-Pay Savings On Treatment.
- Patient Support Program
Details on Our Personal Support
Program & Resources for Patients.
- $0 Co-Pay Offer
Search results
Results From The WOW.Com Content Network
Ankylosing spondylitis (AS) is a type of arthritis from the disease spectrum of axial spondyloarthritis. [5] It is characterized by long-term inflammation of the joints of the spine, typically where the spine joins the pelvis. [2] With AS, eye and bowel problems—as well as back pain—may occur. [2]
The prevalence of ankylosing spondylitis and spondyloarthritis, in particular, varies across populations and is similar to that of HLA-B27. [5] The incidence of spondyloarthritis as a disease entity was recorded in only four investigations, and ranged from 0.48/100,000 in Japan [ 54 ] to 62.5/100,000 in Spain .
With an aging population, this number is expected to increase. Adults with co-morbid conditions, such as heart disease, diabetes, and obesity, were seen to have a higher than average prevalence of doctor-diagnosed arthritis (49.3%, 47.1%, and 30.6% respectively). [106] Disability due to musculoskeletal disorders increased by 45% from 1990 to 2010.
Since the disease ankylosing spondylitis was still defined by the Modified New York criteria of 1984, there was the need to find a new disease term that would also include the less severe forms or early onset of ankylosing spondylitis. This expression was found in the umbrella term axial spondyloarthritis.
The BASDAI or Bath Ankylosing Spondylitis Disease Activity Index is a validated diagnostic test which allows a physician, usually a rheumatologist, to determine the effectiveness of a current drug therapy, or the need to institute a new drug therapy for the treatment of Ankylosing spondylitis (AS).
rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis, Crohn's disease, ulcerative colitis Intetumumab [85] [86] mab: human: CD51: solid tumors (prostate cancer, melanoma) Inolimomab: mab: mouse: CD25 (α chain of IL-2 receptor) graft versus host disease: Inotuzumab ozogamicin [39] Besponsa: mab: humanized: CD22: Y: Acute ...
Ads
related to: ankylosing spondylitis prevalence chart cdc adults